A federal judge has dismissed Tara Moore‘s $20 million lawsuit against the WTA Tour, reinforcing the four-year doping ban that the former British doubles No. 1 is currently serving. The ruling, issued by US District Judge Andrew Carter in New York, concluded there was no legal foundation for Moore’s allegations that the arbitration process was unfair or exceeded its authority.
Moore, 34, has consistently denied any intentional use of banned substances. Despite this, her suspension remains in effect until December 2027, marking a significant setback as she faces the consequences of the doping violation.
Details of Tara Moore’s Doping Suspension
The controversy began in 2022 when Moore tested positive for two anabolic steroids—boldenone and nandrolone—during a tournament in Colombia, leading to her provisional suspension. She contested the WTA’s handling of the situation, asserting that the organization failed to adequately warn players about the potential risk of consuming meat contaminated with steroids.
Initially, an independent tribunal cleared Moore of fault or negligence 19 months later, supporting her claim that she was not intentionally doping. However, the International Tennis Integrity Agency challenged this outcome by appealing to the Court of Arbitration for Sport. The CAS ultimately ruled against Moore, determining she did not sufficiently prove that meat contamination was the source of nandrolone detected in her sample.
Throughout the process, Moore criticized the WTA’s anti-doping procedures, describing the policy as “broken” and the adjudication as “subjective.” Nevertheless, her ban remains upheld, sidelining her from professional tennis until the end of 2027.